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Perfusion cell culture processes have demonstrated higher productivity than fed-batch due to the ability to 
generate and maintain high cell densities over long process durations.  When using a perfusion system, like the 
Repligen XCellTM ATF, a clarified cell free stream of product is continuously generated and is ready for 
downstream purification.  Similarly, continuous or semi-continuous capture chromatography of monoclonal 
antibodies (mAbs) can provide significant advantages over batch processes such as higher productivity, 
improved product quality, lower equipment footprint, and reduced purification cost.  Integrating a perfusion 
system with a continuous downstream purification system could achieve all these advantages over a batch 
system. Multicolumn based chromatography systems (MCC) have been widely evaluated and show tremendous 
benefit when integrated with perfusion processes for continuous purification of mAbs.  However, adoption of 
MCC within the biotech industry has been slow due to complexity of the systems which can be challenging to 
set-up, qualify and come with a higher risk of process failures. In this work, we have combined a single capture 
chromatography column containing a high capacity Protein A resin, Purolite Praesto® Jetted A50, with a 
Repligen XCellTM ATF perfusion cell culture system.  The performance and productivity of this single column 
capture integrated system were compared with MCC approaches.  The high performance single-column system 
simplifies the downstream capture process and is scalable to > 5 kg mAb per day process without the need for 
complicated MCC equipment or operation.  
 
 
